Oligodendroglioma [clinicaltrials_resource:a5a41eb68903bc18aa2f18dcbf3cc8ce]
Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [clinicaltrials:NCT00080054]Prolonged Daily Temozolomide for Low-Grade Glioma [clinicaltrials:NCT00165360]clinicaltrials:NCT00360828clinicaltrials:NCT00389090The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601AM1)(COMPLETED) [clinicaltrials:NCT00392171]clinicaltrials:NCT00575887Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma [clinicaltrials:NCT00591058]A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma [clinicaltrials:NCT00683761]clinicaltrials:NCT00717210Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma [clinicaltrials:NCT00823459]clinicaltrials:NCT00874861FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma [clinicaltrials:NCT01089244]Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma [clinicaltrials:NCT01421524]Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma [clinicaltrials:NCT01649830]Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors [clinicaltrials:NCT01836549]Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas [clinicaltrials:NCT01849952]clinicaltrials:NCT02209428clinicaltrials:NCT02372409
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00002569Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma [clinicaltrials:NCT00002840]Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma [clinicaltrials:NCT00003101]Topotecan in Treating Patients With Recurrent Brain Tumors [clinicaltrials:NCT00003372]Temozolomide in Treating Patients With Anaplastic Oligodendroglioma [clinicaltrials:NCT00003465]Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma [clinicaltrials:NCT00003472]Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma [clinicaltrials:NCT00004024]Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00004078]Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [clinicaltrials:NCT00004688]Bortezomib in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00006773]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Stereotactic Radiosurgery in Treating Patients With Brain Tumors [clinicaltrials:NCT00019578]Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients [clinicaltrials:NCT00024557]Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [clinicaltrials:NCT00024570]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]clinicaltrials:NCT00033280Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00041587]clinicaltrials:NCT00042991Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]clinicaltrials:NCT00049127Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [clinicaltrials:NCT00052780]Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [clinicaltrials:NCT00062504]Cilengitide in Treating Children With Refractory Primary Brain Tumors [clinicaltrials:NCT00063973]Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00064779]Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma [clinicaltrials:NCT00070525]A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [clinicaltrials:NCT00080054]FR901228 in Treating Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00085540]Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00093613]clinicaltrials:NCT00095940Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [clinicaltrials:NCT00100880]Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors [clinicaltrials:NCT00110032]clinicaltrials:NCT00112736Prolonged Daily Temozolomide for Low-Grade Glioma [clinicaltrials:NCT00165360]Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours [clinicaltrials:NCT00213876]Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors [clinicaltrials:NCT00243490]Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [clinicaltrials:NCT00268385]clinicaltrials:NCT00303849
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00002569Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma [clinicaltrials:NCT00002840]Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma [clinicaltrials:NCT00003101]Topotecan in Treating Patients With Recurrent Brain Tumors [clinicaltrials:NCT00003372]Temozolomide in Treating Patients With Anaplastic Oligodendroglioma [clinicaltrials:NCT00003465]Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma [clinicaltrials:NCT00003472]Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma [clinicaltrials:NCT00004024]Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00004078]Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [clinicaltrials:NCT00004688]Bortezomib in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00006773]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Stereotactic Radiosurgery in Treating Patients With Brain Tumors [clinicaltrials:NCT00019578]Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients [clinicaltrials:NCT00024557]Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [clinicaltrials:NCT00024570]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]clinicaltrials:NCT00033280Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00041587]clinicaltrials:NCT00042991Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]clinicaltrials:NCT00049127Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [clinicaltrials:NCT00052780]Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [clinicaltrials:NCT00062504]Cilengitide in Treating Children With Refractory Primary Brain Tumors [clinicaltrials:NCT00063973]Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00064779]Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma [clinicaltrials:NCT00070525]A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [clinicaltrials:NCT00080054]FR901228 in Treating Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00085540]Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00093613]clinicaltrials:NCT00095940Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [clinicaltrials:NCT00100880]Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors [clinicaltrials:NCT00110032]clinicaltrials:NCT00112736Prolonged Daily Temozolomide for Low-Grade Glioma [clinicaltrials:NCT00165360]Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours [clinicaltrials:NCT00213876]Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors [clinicaltrials:NCT00243490]Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [clinicaltrials:NCT00268385]clinicaltrials:NCT00303849
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Oligodendroglioma [clinicaltrials_resource:a5a41eb68903bc18aa2f18dcbf3cc8ce]
Bio2RDF identifier
a5a41eb68903bc18aa2f18dcbf3cc8ce
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a5a41eb68903bc18aa2f18dcbf3cc8ce
identifier
clinicaltrials_resource:a5a41eb68903bc18aa2f18dcbf3cc8ce
title
Oligodendroglioma
@en
type
label
Oligodendroglioma [clinicaltrials_resource:a5a41eb68903bc18aa2f18dcbf3cc8ce]
@en
Oligodendroglioma